Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
about
Normal and neoplastic urothelial stem cells: getting to the root of the problemRegenerative medicine in urologyThe epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiationLoss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.Urothelial signaling.PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaInduction of human embryonic and induced pluripotent stem cells into urothelium.Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium.Differential regulation of growth-promoting signalling pathways by E-cadherin.Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coliPigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cellsFGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.Deregulation of Rab and Rab effector genes in bladder cancer.Differentiation-associated reprogramming of the transforming growth factor β receptor pathway establishes the circuitry for epithelial autocrine/paracrine repairPPARgamma-regulated tight junction development during human urothelial cytodifferentiationTranscriptome analysis of PPARγ target genes reveals the involvement of lysyl oxidase in human placental cytotrophoblast invasionClonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population.Organ-specific matrix self-assembled by mesenchymal cells improves the normal urothelial differentiation in vitro.Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systemsInteraction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.Differentiation potential of urothelium from patients with benign bladder dysfunction.Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.Experimental models of human bladder carcinogenesis.Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases.Increased bladder permeability in interstitial cystitis/painful bladder syndrome.Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing.Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration.Brg1 determines urothelial cell fate during ureter developmentRat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsThe association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney diseaseWhen urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Examining the safety of PPAR agonists - current trends and future prospects.Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Production of urothelium from pluripotent stem cells for regenerative applications.FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.Kruppel-like factor 5 is required for formation and differentiation of the bladder urotheliumThiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors.
P2860
Q26825948-43DC97EF-E917-476A-930F-6C58676E697FQ27006859-6B71E80B-2271-410D-92C5-5B24F3235CB3Q28590746-11542062-834C-4B8C-8F94-A881D5768737Q28730032-8F8CCE7A-6E14-48AD-8CDC-034FDCFE6431Q30440958-809E664D-0B0A-4B83-86F3-43C6CA9B86A9Q33235601-B1E839A4-D252-4B27-8DB3-7CB1659BC6B2Q33551978-697F87FC-411F-46DD-9890-926571316E08Q33652158-53061C80-2ED8-480A-8FAF-E4611DF2262EQ33737721-8F809281-7F69-4955-B67E-23BF6BBDA9A7Q33762850-9104B640-4495-47A4-ACB2-5440FC133098Q34162379-9FA7CB60-E967-49B5-9F31-F836EA181D52Q34305855-22C28673-992A-434A-BF38-DA526A4C5F3DQ34314461-1254AB58-810A-4A18-90BB-F98276090807Q34531854-1E6548E2-4396-4EF2-8251-05A8228E0406Q34863027-030FC64F-DFEB-45FB-968C-072555CACB03Q35050472-5D59740F-9F2E-4E05-8D70-D2982C05DDECQ35108553-5610E18D-FF26-4D53-9BF4-4AB80681341EQ35640762-800427A8-5590-4399-8A76-649BA160CCE0Q35640830-4CAAD6C2-5728-4FC8-9E55-F8E34D1708B6Q35641787-9554D9C1-6E7F-4E24-9FA3-88BD8D226EADQ35966453-F54D4903-16EE-4A33-B1DA-9B6D72855092Q36210174-A92C21BA-9746-43D9-9B54-D359092FA2A0Q36313029-1FE0ACA2-3803-4D9B-A00A-346A0A5DC6BEQ36322834-3DFF8BAC-BBF9-4112-86F4-4AFC97DB1F68Q36445359-064364F3-88CD-4E53-AB35-08D06099C37CQ36446014-2A018351-7CEB-46DA-AA25-05A77108C9E0Q36582849-9719EF89-9008-4892-8810-6EED9BAD613FQ36719270-68E5F7EA-BF90-4E05-B62C-9721B62082F0Q37077098-6775B5AB-2491-4D20-BA9B-DC8FFED3691BQ37464712-B1FEEA96-F355-4C8E-9465-030BD34306EAQ37933675-CEE2A4A2-80DF-491A-BBBC-3CB36B7F9373Q38058381-C0BA08CF-A322-4360-B9C4-7BBF69A5F99BQ38061184-D45DF040-2632-4C6F-9543-6E9E78DF643CQ38222834-8DB757E6-397B-41BB-8080-F9EC35BF0923Q38268939-0BE9CD52-2E9B-4EE5-A60A-55D75D506727Q38288442-1BCEE98A-68FA-4314-A358-325A16461E75Q38329996-E3B61B1A-195A-448F-B3D3-92FE045D19E8Q38570411-DC1F025D-F948-45E6-84D2-43CB61876A70Q38641190-C587B71C-1BCF-4CAF-9722-F2AF628C4199Q38723756-7BBB2FB8-7BB6-41C9-B819-ADEA44A807BB
P2860
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en-gb
type
label
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en-gb
prefLabel
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en-gb
P2093
P50
P356
P1476
Role of PPARgamma and EGFR sig ...... nal differentiation programme.
@en
P2093
Christine Diggle
Claire L Varley
Jens Stahlschmidt
Julie Holder
Ludwik K Trejdosiewicz
Wen-Chun Lee
P304
P356
10.1242/JCS.01042
P407
P577
2004-03-30T00:00:00Z